BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 33495964)

  • 1. Synchronous peritoneal metastases of gastric cancer origin: incidence, treatment and survival of a nationwide Dutch cohort.
    Koemans WJ; Lurvink RJ; Grootscholten C; Verhoeven RHA; de Hingh IH; van Sandick JW
    Gastric Cancer; 2021 Jul; 24(4):800-809. PubMed ID: 33495964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors in patients with loco-regionally advanced gastric cancer.
    Hultman B; Gunnarsson U; Nygren P; Sundbom M; Glimelius B; Mahteme H
    World J Surg Oncol; 2017 Sep; 15(1):172. PubMed ID: 28915886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synchronous peritoneal metastases of small bowel adenocarcinoma: Insights into an underexposed clinical phenomenon.
    Legué LM; Simkens GA; Creemers GM; Lemmens VEPP; de Hingh IHJT
    Eur J Cancer; 2017 Dec; 87():84-91. PubMed ID: 29132061
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence, Treatment, and Survival of Synchronous Peritoneal Metastases in Pancreatic Cancer: Update of a Nationwide Cohort.
    Rijken A; Bakkers C; van Erning FN; van der Geest LG; de Vos-Geelen J; Besselink MG; Lemmens VE; de Hingh IHJT;
    Pancreas; 2021 Jul; 50(6):827-833. PubMed ID: 34347730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peritoneal metastases from gastric cancer in a nationwide cohort: Incidence, treatment and survival.
    Rijken A; Pape M; Simkens GA; de Hingh IHJT; Luyer MDP; van Sandick JW; van Laarhoven HWM; Verhoeven RHA; van Erning FN
    Int J Cancer; 2024 Mar; 154(6):992-1002. PubMed ID: 37916797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy versus palliative systemic chemotherapy in stomach cancer patients with peritoneal dissemination, the study protocol of a multicentre randomised controlled trial (PERISCOPE II).
    Koemans WJ; van der Kaaij RT; Boot H; Buffart T; Veenhof AAFA; Hartemink KJ; Grootscholten C; Snaebjornsson P; Retel VP; van Tinteren H; Vanhoutvin S; van der Noort V; Houwink A; Hahn C; Huitema ADR; Lahaye M; Los M; van den Barselaar P; Imhof O; Aalbers A; van Dam GM; van Etten B; Wijnhoven BPL; Luyer MDP; Boerma D; van Sandick JW
    BMC Cancer; 2019 May; 19(1):420. PubMed ID: 31060544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Population-based incidence, treatment and survival of patients with peritoneal metastases of unknown origin.
    Thomassen I; Verhoeven RH; van Gestel YR; van de Wouw AJ; Lemmens VE; de Hingh IH
    Eur J Cancer; 2014 Jan; 50(1):50-6. PubMed ID: 24011935
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy improves survival of patients with peritoneal carcinomatosis from gastric cancer: final results of a phase III randomized clinical trial.
    Yang XJ; Huang CQ; Suo T; Mei LJ; Yang GL; Cheng FL; Zhou YF; Xiong B; Yonemura Y; Li Y
    Ann Surg Oncol; 2011 Jun; 18(6):1575-81. PubMed ID: 21431408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of maximal cytoreductive surgery plus regional heated intraperitoneal chemotherapy (HIPEC) on outcome of patients with peritoneal carcinomatosis of gastric origin: results of the GYMSSA trial.
    Rudloff U; Langan RC; Mullinax JE; Beane JD; Steinberg SM; Beresnev T; Webb CC; Walker M; Toomey MA; Schrump D; Pandalai P; Stojadinovic A; Avital I
    J Surg Oncol; 2014 Sep; 110(3):275-84. PubMed ID: 25042700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum.
    Hagiwara A; Sawai K; Sakakura C; Shirasu M; Ohgaki M; Yamasaki J; Togawa T; Takahashi T
    Hepatogastroenterology; 1998; 45(23):1922-9. PubMed ID: 9840177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritoneal metastasis in gastric cancer: results from the German database.
    Rau B; Brandl A; Piso P; Pelz J; Busch P; Demtröder C; Schüle S; Schlitt HJ; Roitman M; Tepel J; Sulkowski U; Uzunoglu F; Hünerbein M; Hörbelt R; Ströhlein M; Beckert S; Königsrainer I; Königsrainer A;
    Gastric Cancer; 2020 Jan; 23(1):11-22. PubMed ID: 31228044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors correlated with peritoneal carcinomatosis and survival in patients with gastric cancer treated at a single institution in Brazil.
    Fanelli MF; Silva MJ; de Paiva TF; Chinen LT; Guimarães AP; Gimenes DL; Pinheiro ED; Rinck JA; Nicolau UR; Sanches SM; Melo CA; Dettino AL; Cruz MR; de Melo LM; Formiga MN; de Lima VC
    Int J Clin Oncol; 2009 Aug; 14(4):326-31. PubMed ID: 19705243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extensive gastrectomy and carbon-adsorbed mitomycin C for gastric cancer with peritoneal metastases. Case reports of survivors and their implications.
    Hagiwara A; Togawa T; Yamasaki J; Ohgaki M; Imanishi T; Shirasu M; Sakakura C; Yamaguchi T; Sawai K; Yamagishi H
    Hepatogastroenterology; 1999; 46(27):1673-7. PubMed ID: 10430319
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
    Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
    Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive factors improving survival after gastrectomy in gastric cancer patients with peritoneal carcinomatosis.
    Hioki M; Gotohda N; Konishi M; Nakagohri T; Takahashi S; Kinoshita T
    World J Surg; 2010 Mar; 34(3):555-62. PubMed ID: 20082194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The efficacy of treatment options for patients with gastric cancer and peritoneal metastasis.
    Rau B; Brandl A; Thuss-Patience P; Bergner F; Raue W; Arnold A; Horst D; Pratschke J; Biebl M
    Gastric Cancer; 2019 Nov; 22(6):1226-1237. PubMed ID: 31065877
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bevacizumab in Addition to Palliative Chemotherapy for Patients With Peritoneal Carcinomatosis of Colorectal Origin: A Nationwide Population-Based Study.
    Razenberg LG; van Gestel YR; Lemmens VE; de Hingh IH; Creemers GJ
    Clin Colorectal Cancer; 2016 Jun; 15(2):e41-6. PubMed ID: 26762572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases.
    Wang YN; Shen KT; Ling JQ; Gao XD; Hou YY; Wang XF; Qin J; Sun YH; Qin XY
    BMC Surg; 2012 Oct; 12():20. PubMed ID: 23062030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The critical role of peritoneal cytology in the staging of gastric cancer: an evidence-based review.
    De Andrade JP; Mezhir JJ
    J Surg Oncol; 2014 Sep; 110(3):291-7. PubMed ID: 24850538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gastric cancer with metastases to the distant peritoneum: a 20-year surgical experience.
    Kikuchi S; Arai Y; Morise M; Kobayashi N; Tsukamoto H; Shimao H; Sakakibara Y; Hiki Y; Kakita A
    Hepatogastroenterology; 1998; 45(22):1183-8. PubMed ID: 9756030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.